Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03354416 · ClinicalTrials.gov registry record
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
A clinical trial of Prostate Cancer and Cancer Of Prostate, sponsored by National Cancer Institute (NCI).
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT03354416 is a study of Prostate Cancer and Cancer Of Prostate that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 10,000 participants, above the 595-participant average among 735 other Prostate Cancer trials with a reported enrollment target (1581% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03354416, a study of Prostate Cancer and Cancer Of Prostate, is actively recruiting participants, sponsored by National Cancer Institute (NCI).
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Prostate cancer is one of the most common cancers for men in the U.S. There are some new ways to take pictures of the cancer. There are also new ways to use image-guided biopsy and therapy. These could help manage prostate cancer. Researchers want to study how imaging can provide a profile of prostate cancer. They want to collect data to make diagnosis and treatments better. Objectives: To gather data about the radiological and clinical course of prostate cancer. To study imaging-based biomarkers of prostate cancer. Eligibility: Men ages 18 and older with diagnosed or suspected prostate cancer Design: Participants will give permission for researchers to use their medical history and records. Their data will be reviewed, collected, and analyzed. These include results of their tests and scans. Sponsoring Institution: National Cancer Institute
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2018-02-26 |
| Est. Completion | 2033-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03354416
The ClinicalTrials.gov registry entry for NCT03354416 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 595-participant average among 735 other Prostate Cancer trials with a reported enrollment target (1581% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT03354416 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT03354416 about?
NCT03354416 is a clinical study titled "Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer". Background: Prostate cancer is one of the most common cancers for men in the U.S. There are some new ways to take pictures of the cancer. There are also new ways to use image-guided biopsy and therapy. These could help manage prostate cancer. Researchers want to study how imaging can provide a prof...
What is the current status of trial NCT03354416?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2018-02-26. Estimated completion is 2033-12-31.
What conditions does trial NCT03354416 study?
This clinical trial studies the following conditions: Prostate Cancer, Cancer Of Prostate, Prostatic Hyperplasia, Prostatic Cancer, Prostatic Neoplams.
Who is sponsoring clinical trial NCT03354416?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03354416 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
RECRUITING
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.